Trial Profile
A randomised, double blind, placebo controlled parallel group, 12 week study with COPD [chronic obstructive pulmonary disease] patients naive of anticholinergic agents comparing the effect once daily tiotropium lactose capsule with the patients usual care
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Dec 2008
Price :
$35
*
At a glance
- Drugs Tiotropium bromide (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- Sponsors Boehringer Ingelheim
- 27 Mar 2007 New trial record.